J.L. Balibrea

710 total citations
18 papers, 562 citations indexed

About

J.L. Balibrea is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, J.L. Balibrea has authored 18 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Surgery and 6 papers in Pathology and Forensic Medicine. Recurrent topics in J.L. Balibrea's work include Genetic factors in colorectal cancer (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Telomeres, Telomerase, and Senescence (3 papers). J.L. Balibrea is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Telomeres, Telomerase, and Senescence (3 papers). J.L. Balibrea collaborates with scholars based in Spain, United Kingdom and Italy. J.L. Balibrea's co-authors include Javier Martínez, Paolo Prandoni, V V Kakkar, Carmen de Juan, Pilar Iniesta, Manuel Benito, Andrés Sánchez-Pernaute, Cristina García-Aranda, Antonio Díaz‐López and Eduardo Díaz‐Rubio and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Thorax.

In The Last Decade

J.L. Balibrea

17 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.L. Balibrea Spain 12 201 150 143 138 113 18 562
Doyeun Oh South Korea 15 190 0.9× 107 0.7× 110 0.8× 84 0.6× 163 1.4× 29 552
M. Sinn Germany 9 142 0.7× 291 1.9× 103 0.7× 106 0.8× 69 0.6× 19 517
G.-F. von Tempelhoff Germany 9 153 0.8× 54 0.4× 99 0.7× 53 0.4× 50 0.4× 24 366
J Clavier France 10 159 0.8× 194 1.3× 97 0.7× 66 0.5× 36 0.3× 33 472
H. Lacroix Belgium 13 112 0.6× 273 1.8× 112 0.8× 236 1.7× 116 1.0× 39 726
Andrew McQuillan Australia 10 291 1.4× 37 0.2× 237 1.7× 90 0.7× 93 0.8× 19 571
Jean Chidiac France 11 172 0.9× 72 0.5× 152 1.1× 62 0.4× 63 0.6× 23 371
Dana E. Angelini United States 13 211 1.0× 75 0.5× 139 1.0× 95 0.7× 33 0.3× 41 499
I. Yudelman United States 7 110 0.5× 49 0.3× 145 1.0× 86 0.6× 49 0.4× 12 662
Milena Todorović Serbia 12 63 0.3× 173 1.2× 27 0.2× 54 0.4× 76 0.7× 76 514

Countries citing papers authored by J.L. Balibrea

Since Specialization
Citations

This map shows the geographic impact of J.L. Balibrea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Balibrea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Balibrea more than expected).

Fields of papers citing papers by J.L. Balibrea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Balibrea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Balibrea. The network helps show where J.L. Balibrea may publish in the future.

Co-authorship network of co-authors of J.L. Balibrea

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Balibrea. A scholar is included among the top collaborators of J.L. Balibrea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Balibrea. J.L. Balibrea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kakkar, V V, J.L. Balibrea, Javier Martínez, & Paolo Prandoni. (2010). Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. Journal of Thrombosis and Haemostasis. 8(6). 1223–1229. 193 indexed citations
2.
Iniesta, Pilar, Alberto Morán, Carmen de Juan, et al.. (2007). Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer. Oncology Reports. 17(1). 217–23. 61 indexed citations
3.
Balibrea, J.L., et al.. (2006). Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: An audit of practice. International Journal of Surgery. 5(2). 114–119. 16 indexed citations
4.
García‐Botella, Alejandra, Luis Díez-Valladares, Andrés Sánchez-Pernaute, et al.. (2006). Epithelioid hemangioendothelioma of the liver. Journal of Hepato-Biliary-Pancreatic Surgery. 13(2). 167–171. 22 indexed citations
5.
Sánchez-Pernaute, Andrés, Elia Pérez-Aguirre, Pilar Iniesta, et al.. (2005). Overexpression of c-myc and loss of heterozigosity on 2p, 3p, 5q, 17p and 18q in sporadic colorectal carcinoma. Revista Española de Enfermedades Digestivas. 97(3). 169–78. 5 indexed citations
6.
García-Aranda, Cristina, Carmen de Juan, Antonio Díaz‐López, et al.. (2005). Correlations of telomere length, telomerase activity, and telomeric‐repeat binding factor 1 expression in colorectal carcinoma. Cancer. 106(3). 541–551. 84 indexed citations
7.
Gonzalez‐Quevedo, Rosa, Cristina García-Aranda, Alberto Morán, et al.. (2004). Differential impact of p16 inactivation by promoter methylation in non-small cell lung and colorectal cancer: Clinical implications. International Journal of Oncology. 24(2). 349–55. 25 indexed citations
8.
Gonzalez‐Quevedo, Rosa, Pilar Iniesta, Alberto Morán, et al.. (2002). Cooperative Role of Telomerase Activity and p16 Expression in the Prognosis of Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 20(1). 254–262. 8 indexed citations
9.
Cascón, Alberto, et al.. (2001). Intususcepción yeyunogástrica. Cirugía Española. 69(2). 173–175. 1 indexed citations
10.
Gonzalez‐Quevedo, Rosa, Carmen de Juan, Andrés Sánchez-Pernaute, et al.. (2000). Detection of telomerase activity in human carcinomas using a trap-ELISA method: correlation with hTR and hTERT expression.. International Journal of Oncology. 16(3). 623–8. 19 indexed citations
11.
Iniesta, Pilar, et al.. (2000). Loss of heterozygosity at 3p23 is correlated with poor survival in patients with colorectal carcinoma. Cancer. 89(6). 1220–1227. 14 indexed citations
12.
Iniesta, Pilar, Rosa Gonzalez‐Quevedo, Carmen de Juan, et al.. (1999). Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer. European Journal of Cancer. 35(12). 1676–1682. 26 indexed citations
13.
Iniesta, Pilar, Carmen de Juan, Trinidad Caldés, et al.. (1998). Genetic Abnormalities and Microsatellite Instability in Colorectal Cancer. Cancer Detection and Prevention. 22(5). 383–395. 7 indexed citations
14.
Gómez, Andrés González, Francisco J. Vizoso, Julio Vázquez, Á. Ruibal, & J.L. Balibrea. (1997). Clinical Significance of Preoperative Serum Levels of CA 125 and TAG-72 in Ovarian Carcinoma. The International Journal of Biological Markers. 12(3). 112–117. 3 indexed citations
15.
Torres-Melero, Juan, Javier Arias‐Díaz, & J.L. Balibrea. (1996). Pneumomediastinum secondary to use of a high speed air turbine drill during a dental extraction.. Thorax. 51(3). 339–341. 32 indexed citations
16.
Vizoso, Francisco J., et al.. (1996). Preoperative CEA and TAG-72 Serum Levels as Prognostic Indicators in Resectable Gastric Carcinoma. The International Journal of Biological Markers. 11(3). 165–171. 17 indexed citations
17.
Pollán, Marina, et al.. (1995). Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.. PubMed. 14(6B). 2819–25. 19 indexed citations
18.
Díez‐Alonso, Manuel, et al.. (1990). Tumor Markers in Pancreatic Cancer: A Comparative Clinical Study between CEA, CA 19-9 and CA 50. The International Journal of Biological Markers. 5(3). 127–132. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doyeun Oh Breakdown of academic impact, for papers by M. Sinn Breakdown of academic impact, for papers by G.-F. von Tempelhoff Breakdown of academic impact, for papers by J Clavier Breakdown of academic impact, for papers by H. Lacroix Breakdown of academic impact, for papers by Andrew McQuillan Breakdown of academic impact, for papers by Jean Chidiac Breakdown of academic impact, for papers by Dana E. Angelini Breakdown of academic impact, for papers by I. Yudelman Breakdown of academic impact, for papers by Milena Todorović
Rankless by CCL
2026